According to the "Tianyun" report, the investigation of the "Qianjian Incident" joint investigation team found that Quanjian was suspected of committing crimes on January 1, 2019, in connection with suspected pyramid scheme crimes and suspected false advertising crimes. Conduct a case investigation.

At the same time, the relevant departments have investigated and punished fire-fighting health-care places that do not meet the fire safety regulations, and carried out special actions to focus on clean-up and rectification of health care products.

At the end of the year and the beginning of the year, the hottest thing is the "clove doctor's hand tearing power" this drama! Among the Quanjian products, in addition to media exposure to the treatment of prostatitis sanitary napkins, massage insoles with millions of massage points, liquid beverages for all diseases, Fangxiang Research Institute found that not only declared "high-tech enterprises" Quan Jian claims that he can “cover all kinds of diseases” and sell natural patents to Quan Jian. The patents applied for can also “cure all diseases”.

Quanjian's only drug patent system is bought

Fangxiang Research Institute found that among the 32 patents held by Quanjian Natural Medicine Technology Development Co., Ltd., there is only one drug patent, which is “a Chinese medicine for treating chronic erosive gastritis” with the patent number CN103055181 (see below). Figure).

Table 1: List of patents held by Quanjian

Source: Fangxiang Research Institute

This patent, which is known as "a traditional Chinese medicine for treating chronic erosive gastritis", seems to be more technically valuable because it has been "proven clinically proven" and "can safely and effectively treat chronic erosive gastritis". However, Fangfang Research Institute found that Quanjian’s only pharmaceutical patent was not developed by itself.

Quan Jian’s acquisition of technology is not a secret. Quan Jian’s official has repeatedly publicized its traditional recipe for acquiring Chinese medicine and health products. On the right health official website, the identity of the boss, Shu Huihui, is "an ancient secret recipe." Then, is this patent for treating stomach diseases, like the rumor that Quan Jian, “80 million purchased tumor secrets”, also has high technical value?

Source: Quanjian's official website

Patent business card

Title: A Traditional Chinese Medicine for Treating Chronic Erosive Gastritis

Patent Type: Invention

Publication number: CN103055181

IPC (Main Category): A61K36/899

Application date: 20130114

2013.04.24 Public

2013.05.29 Effective entry of substantive examination

2014.02.05 Transfer of patent application rights and patent rights

Change: Applicant

Pre-change rights holder: X Jun

Rights holder after the change: Quanjian Natural Medicine Technology Development Co., Ltd.

Change item: address

Pre-change right holder: 315181 No. 50, Hengjie East Road, Hengjie Town, Yinzhou District, Ningbo, Zhejiang, China

Rights holder after change: 301707 No. 1 Quanjian Road, Douzhangzhuang Township, Wuqing District, Tianjin

Registration effective date: 20140108

2014.02.05 Change of the record

Change item: inventor

Before the change: X Jun

After the change: Shu Huihui

2014.02.12 Authorization

Source: Fangxiang Research Institute

31 patents of the transferor

The Fangxiang Research Institute further inquired that the original inventor and right holder of the patent were natural persons X Jun (pseudonym).

The 31 patents that X Jun applied for (see the table below) are all related to Chinese medicine. The diseases treated by these patented drugs include pelvic inflammatory disease, breast hyperplasia, fatty liver, systemic lupus erythematosus, uterine cold infertility, sinusitis, diabetic foot ulcer, psoriasis, menopausal syndrome... The scope of treatment involves gynecology, hepatology, Immunology, reproductive health, otolaryngology, endocrinology, dermatology, reproductive endocrinology and many other intractable diseases.

Table 2: List of patents held by X Jun

Source: Fangxiang Research Institute

Further research by the Fangxiang Research Institute found that among the 31 patents that X Jun once held, only 8 valid patents have been transferred, including the transfer to Quan Jian, “a treatment for chronic erosive gastritis. traditional Chinese medicine".

The specific analysis found that the eight patent transfer paths are consistent: 1. Submit the original application; 2. After the patent is disclosed and the substantive examination takes effect, the patent right is transferred to the assignee and the inventor is changed accordingly; The patent is authorized.

In the know-how transaction, this kind of trading path is common in the "industrial chain" for the purpose of "selling patents". After the applicant applies for a patent, he directly sells it to the invention patent "additional points", "appraisal title", and " All kinds of subjects packaged through high-tech certification or product technology upgrade. If such patents have real technical value, they need to be verified.

Quan Jian buy patent map is still the effect of packaging?

Fangxiang Zhicai Research Institute found that among the 31 patents held by X Jun, except for one patent that was still under substantive examination and eight valid patents, the remaining 22 patents were rejected and some were After the review took effect, it was withdrawn by itself, and some of the authorizations were obtained but expired due to the failure to pay the annual fee.

In other words, after X applied for or granted a patent, if it was not transferred in time, even if it was authorized, it would not pay the annual fee or even give up. The value of such patent technology can be seen.

Looking back, look at the patent that X Jun transferred to Quan Jian, “a traditional Chinese medicine for treating chronic erosive gastritis.” Whether it is favored by Quan Jian with its unique technical value, or it happens that Quan Jian needs to buy a patent to package himself. What? For the technical value of related patents, Fangxiang Research Institute will continue to pay attention and conduct in-depth analysis.

Square view: patent chaos

On December 3, 2018, the World Intellectual Property Index's annual report (WIPI) released by the World Intellectual Property Organization showed that there were 3.17 million patent applications worldwide in 2017, of which the National Intellectual Property Office of China accepted 1.38 million patent applications. Ranked first in the world, larger than the United States (600,000), Japan (310,000), South Korea (200,000), the European Union Patent Office (160,000) applied for the sum of patents.

The discussion about the large number of patents in China but the scarcity of high-quality patents has become a commonplace. A large number of low-value or even worthless patents not only lower the overall level of patents, waste social resources, but also mislead intellectual property strategic decisions, but also give some technical strength. The enterprise can take advantage of the opportunity to package products with no technical content into patents with "high-tech value" through patents without technical value, misleading and deceiving investors and consumers.

Technology investors can seek help through their internal research departments or to professional technology value research institutions to identify the technology "Li Gui"; ordinary investors fear that it is difficult to identify and enter the pit; and those who refuse Western medicine treatment only pay for the secret recipe. Patients and ordinary consumers are less able to have basic recognition skills.

Simply pursue the number of patents, blindly encourage the application of "honor" patents, improper funding and acquisition of patents, when rest!

Disposable Nitrile Gloves T

ZHANGJIAGANG DINSHENGLIN TRADING CO.,LTD , https://www.dslhouse.com